FindTrial
Sign In

Study on the MDT standard and model of the HIFU treatment for pancreatic cancer

Study on the MDT standard and model of the HIFU treatment for pancreatic cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONC-16009445
Enrollment
Unknown
Registered
2016-10-16
Start date
2016-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreas Cancer

Interventions

HIFU treatment group:HIFU treatment under MDT mode

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Pancreas cancer who can not tolerate surgery; (2) tumor can not be removed by surgery; (3) the expected survival of more than 3 months; (4) the lesion(s) can be clearly shown in the airborne ultrasound; (5) no obvious obstructive jaundice; (6) enough sound channel; (7) signed informed consent

Exclusion criteria

Exclusion criteria: (1) Refuse to sign the informed consent; (2) ultrasound visualization of the lesion is not clear; (3) there are medical implantsin sound channel of HIFU treatment; (4) uncorrectable obstructive jaundice; (5)pancreatic cancer had received more than 45Gy radiotherapy.

Design outcomes

Primary

MeasureTime frame
Tumor size and inactivation;tumor marker level;clinical benefit rate;score of life quality;—

Countries

China

Contacts

Public ContactZhu Zhongzheng

Shanghai Tenth People's Hospital

zzzhu1170@yeah.net+86 13817057105

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026